Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.

Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R.

Neuropsychopharmacol Rep. 2020 Feb 5. doi: 10.1002/npr2.12098. [Epub ahead of print]

2.

Genetic combination risk for schizophrenia.

Oishi K, Niitsu T, Kanahara N, Hashimoto T, Komatsu H, Sasaki T, Takase M, Sato Y, Iyo M.

Schizophr Res. 2020 Jan;215:473-474. doi: 10.1016/j.schres.2019.08.021. Epub 2019 Aug 30. No abstract available.

PMID:
31477374
3.

End-of-life care in the pediatric intensive care unit: Survey in Japan.

Seino Y, Kurosawa H, Shiima Y, Niitsu T.

Pediatr Int. 2019 Sep;61(9):859-864. doi: 10.1111/ped.13924.

PMID:
31247125
4.

Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.

Oishi K, Kanahara N, Takase M, Oda Y, Nakata Y, Niitsu T, Ishikawa M, Sato Y, Iyo M.

PLoS One. 2018 Nov 8;13(11):e0207133. doi: 10.1371/journal.pone.0207133. eCollection 2018.

5.

Psychological Distress Symptoms Associated With Life Events in Patients With Bipolar Disorder: A Cross-Sectional Study.

Sato A, Hashimoto T, Kimura A, Niitsu T, Iyo M.

Front Psychiatry. 2018 May 23;9:200. doi: 10.3389/fpsyt.2018.00200. eCollection 2018.

6.

Association between uncooperativeness and the glucose metabolism of patients with chronic behavioral disorders after severe traumatic brain injury: a cross-sectional retrospective study.

Yamaki T, Suzuki K, Sudo Y, Niitsu T, Okai M, Oka N, Odaki M.

Biopsychosoc Med. 2018 Apr 23;12:6. doi: 10.1186/s13030-018-0125-0. eCollection 2018.

7.

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia.

Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R.

Int J Neuropsychopharmacol. 2018 Jul 1;21(7):631-639. doi: 10.1093/ijnp/pyy013.

8.

Effect of educational intervention on attitudes toward the concept of criminal responsibility.

Shiina A, Niitsu T, Sato A, Omiya S, Nagata T, Tomoto A, Watanabe H, Igarashi Y, Iyo M.

World J Psychiatry. 2017 Dec 22;7(4):197-206. doi: 10.5498/wjp.v7.i4.197. eCollection 2017 Dec 22.

9.

Site-Seeing: Hereditary Hemorrhagic Telangiectasia with Native-Valve Endocarditis.

Kawahigashi T, Nishiguchi S, Branch J, Hiramitsu K, Niitsu T, Kitagawa I.

Am J Med. 2018 Apr;131(4):380-383. doi: 10.1016/j.amjmed.2017.11.037. Epub 2017 Dec 18. No abstract available.

PMID:
29269227
10.

Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.

Oda Y, Fujita Y, Oishi K, Nakata Y, Takase M, Niitsu T, Kanahara N, Shirayama Y, Hashimoto K, Iyo M.

Psychopharmacology (Berl). 2017 Oct;234(20):3027-3036. doi: 10.1007/s00213-017-4695-5. Epub 2017 Jul 25.

PMID:
28744562
11.

The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia.

Takase M, Kanahara N, Oda Y, Niitsu T, Watanabe H, Iyo M.

Schizophr Res. 2017 Dec;190:182-183. doi: 10.1016/j.schres.2017.03.014. Epub 2017 Mar 9. No abstract available.

PMID:
28285026
12.

Effectiveness of blonanserin for patients with drug treatment-resistant schizophrenia and dopamine supersensitivity: A retrospective analysis.

Tachibana M, Niitsu T, Watanabe M, Hashimoto T, Kanahara N, Ishikawa M, Iyo M.

Asian J Psychiatr. 2016 Dec;24:28-32. doi: 10.1016/j.ajp.2016.08.014. Epub 2016 Aug 18.

PMID:
27931902
13.

Altered serum level of matrix metalloproteinase-9 and its association with decision-making in eating disorders.

Matsumoto J, Hirano Y, Hashimoto K, Ishima T, Kanahara N, Niitsu T, Shiina A, Hashimoto T, Sato Y, Yokote K, Murano S, Kimura H, Hosoda Y, Shimizu E, Iyo M, Nakazato M.

Psychiatry Clin Neurosci. 2017 Feb;71(2):124-134. doi: 10.1111/pcn.12490. Epub 2017 Jan 14.

14.

Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial.

Hashimoto T, Shiina A, Hasegawa T, Kimura H, Oda Y, Niitsu T, Ishikawa M, Tachibana M, Muneoka K, Matsuki S, Nakazato M, Iyo M.

Ann Gen Psychiatry. 2016 Oct 19;15:27. eCollection 2016.

15.

A questionnaire survey regarding the support needed by Yogo teachers to take care of students suspected of having eating disorders (second report).

Seike K, Nakazato M, Hanazawa H, Ohtani T, Niitsu T, Ishikawa SI, Ayabe A, Otani R, Kawabe K, Horiuchi F, Takamiya S, Sakuta R.

Biopsychosoc Med. 2016 Sep 29;10:28. eCollection 2016.

16.

Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group.

Sasaki T, Hashimoto K, Oda Y, Ishima T, Yakita M, Kurata T, Kunou M, Takahashi J, Kamata Y, Kimura A, Niitsu T, Komatsu H, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shimizu E, Iyo M.

PLoS One. 2016 Aug 18;11(8):e0160767. doi: 10.1371/journal.pone.0160767. eCollection 2016.

17.

Cognitive Behavioral Therapy for Patients with Social Anxiety Disorder Who Remain Symptomatic following Antidepressant Treatment: A Randomized, Assessor-Blinded, Controlled Trial.

Yoshinaga N, Matsuki S, Niitsu T, Sato Y, Tanaka M, Ibuki H, Takanashi R, Ohshiro K, Ohshima F, Asano K, Kobori O, Yoshimura K, Hirano Y, Sawaguchi K, Koshizaka M, Hanaoka H, Nakagawa A, Nakazato M, Iyo M, Shimizu E.

Psychother Psychosom. 2016;85(4):208-17. doi: 10.1159/000444221. Epub 2016 May 27.

18.

Increased serum levels of serine enantiomers in patients with depression.

Hashimoto K, Yoshida T, Ishikawa M, Fujita Y, Niitsu T, Nakazato M, Watanabe H, Sasaki T, Shiina A, Hashimoto T, Kanahara N, Hasegawa T, Enohara M, Kimura A, Iyo M.

Acta Neuropsychiatr. 2016 Jun;28(3):173-8. doi: 10.1017/neu.2015.59. Epub 2015 Oct 29.

PMID:
26512905
19.

Simulation-based training for determination of brain death by pediatric healthcare providers.

Araki T, Yokota H, Ichikawa K, Osamura T, Satomi A, Tsuru T, Umehara M, Niitsu T, Yamamoto T, Nishiyama K.

Springerplus. 2015 Aug 12;4:412. doi: 10.1186/s40064-015-1211-4. eCollection 2015.

20.

Decreased levels of serum oxytocin in pediatric patients with Attention Deficit/Hyperactivity Disorder.

Sasaki T, Hashimoto K, Oda Y, Ishima T, Kurata T, Takahashi J, Kamata Y, Kimura H, Niitsu T, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M.

Psychiatry Res. 2015 Aug 30;228(3):746-51. doi: 10.1016/j.psychres.2015.05.029. Epub 2015 Jun 15.

21.

Predictors of switch from depression to mania in bipolar disorder.

Niitsu T, Fabbri C, Serretti A.

J Psychiatr Res. 2015 Jul-Aug;66-67:45-53. doi: 10.1016/j.jpsychires.2015.04.014. Epub 2015 Apr 22.

PMID:
25937504
22.

Presence of psychological distress symptoms associated with onset-related life events in patients with treatment-refractory depression.

Kimura A, Hashimoto T, Niitsu T, Iyo M.

J Affect Disord. 2015 Apr 1;175:303-9. doi: 10.1016/j.jad.2015.01.027. Epub 2015 Jan 22.

PMID:
25661396
23.

Deficits in emotion based decision-making in schizophrenia; a new insight based on the Iowa Gambling Task.

Matsuzawa D, Shirayama Y, Niitsu T, Hashimoto K, Iyo M.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:52-9. doi: 10.1016/j.pnpbp.2014.10.007. Epub 2014 Oct 24.

PMID:
25455588
24.

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.

Fabbri C, Minarini A, Niitsu T, Serretti A.

Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1093-118. doi: 10.1517/17425255.2014.928693. Epub 2014 Jun 14. Review.

PMID:
24930681
25.

Second-generation antipsychotics and bone turnover in schizophrenia.

Okita K, Kanahara N, Nishimura M, Yoshida T, Yasui-Furukori N, Niitsu T, Yoshida T, Ishikawa M, Kimura H, Nomura F, Iyo M.

Schizophr Res. 2014 Aug;157(1-3):137-41. doi: 10.1016/j.schres.2014.05.009. Epub 2014 Jun 2.

PMID:
24888527
26.

The psychological impact of a dual-disaster caused by earthquakes and radioactive contamination in Ichinoseki after the Great East Japan Earthquake.

Niitsu T, Takaoka K, Uemura S, Kono A, Saito A, Kawakami N, Nakazato M, Shimizu E.

BMC Res Notes. 2014 May 20;7:307. doi: 10.1186/1756-0500-7-307.

27.

Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia.

Niitsu T, Shirayama Y, Matsuzawa D, Shimizu E, Hashimoto K, Iyo M.

Neurosci Lett. 2014 Jul 11;575:37-41. doi: 10.1016/j.neulet.2014.05.034. Epub 2014 May 24.

PMID:
24861509
28.

A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia.

Niitsu T, Ishima T, Yoshida T, Hashimoto T, Matsuzawa D, Shirayama Y, Nakazato M, Shimizu E, Hashimoto K, Iyo M.

Psychiatry Res. 2014 Feb 28;215(2):268-73. doi: 10.1016/j.psychres.2013.12.009. Epub 2013 Dec 14.

PMID:
24377440
29.
30.

Pharmacogenetics in major depression: a comprehensive meta-analysis.

Niitsu T, Fabbri C, Bentini F, Serretti A.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:183-94. doi: 10.1016/j.pnpbp.2013.05.011. Epub 2013 Jun 1. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:118-9.

PMID:
23733030
31.

Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.

Iyo M, Tadokoro S, Kanahara N, Hashimoto T, Niitsu T, Watanabe H, Hashimoto K.

J Clin Psychopharmacol. 2013 Jun;33(3):398-404. doi: 10.1097/JCP.0b013e31828ea95c. Review.

PMID:
23609386
32.

Changes in self-regulation-related prefrontal activities in eating disorders: a near infrared spectroscopy study.

Sutoh C, Nakazato M, Matsuzawa D, Tsuru K, Niitsu T, Iyo M, Shimizu E.

PLoS One. 2013;8(3):e59324. doi: 10.1371/journal.pone.0059324. Epub 2013 Mar 19.

33.

Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment.

Yoshinaga N, Niitsu T, Hanaoka H, Sato Y, Ohshima F, Matsuki S, Kobori O, Nakazato M, Nakagawa A, Iyo M, Shimizu E.

BMJ Open. 2013 Feb 13;3(2). pii: e002242. doi: 10.1136/bmjopen-2012-002242. Print 2013.

34.

A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study.

Niitsu T, Fujisaki M, Shiina A, Yoshida T, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Fukami G, Nakazato M, Shirayama Y, Hashimoto K, Iyo M.

J Clin Psychopharmacol. 2012 Oct;32(5):593-601. doi: 10.1097/JCP.0b013e3182664cfc.

PMID:
22926591
35.

Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.

Yoshida T, Ishikawa M, Niitsu T, Nakazato M, Watanabe H, Shiraishi T, Shiina A, Hashimoto T, Kanahara N, Hasegawa T, Enohara M, Kimura A, Iyo M, Hashimoto K.

PLoS One. 2012;7(8):e42676. doi: 10.1371/journal.pone.0042676. Epub 2012 Aug 3. Erratum in: PLoS One. 2013;8(2). doi:10.1371/annotation/85a3fa48-980b-4f95-bb43-b33b1c3e0ac6.

36.

Treatment of refractory catatonic schizophrenia with low dose aripiprazole.

Sasaki T, Hashimoto T, Niitsu T, Kanahara N, Iyo M.

Ann Gen Psychiatry. 2012 May 3;11(1):12. doi: 10.1186/1744-859X-11-12.

37.

Possible involvement of brain-derived neurotrophic factor in eating disorders.

Nakazato M, Hashimoto K, Shimizu E, Niitsu T, Iyo M.

IUBMB Life. 2012 May;64(5):355-61. doi: 10.1002/iub.1012. Epub 2012 Apr 4. Review.

38.

Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases.

Niitsu T, Iyo M, Hashimoto K.

Curr Pharm Des. 2012;18(7):875-83. Review.

PMID:
22288409
39.

Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.

Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami G, Fujisaki M, Watanabe H, Nakazato M, Asano M, Kimura S, Hashimoto K, Iyo M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1836-40. doi: 10.1016/j.pnpbp.2011.09.004. Epub 2011 Sep 10.

PMID:
21930178
40.

Cyclooxygenase inhibition in ventilator-induced lung injury.

Niitsu T, Tsuchida S, Peltekova V, Engelberts D, Copland I, Otulakowski G, Post M, Kavanagh BP.

Anesth Analg. 2011 Jan;112(1):143-9. doi: 10.1213/ANE.0b013e3181fe4841. Epub 2010 Nov 3.

PMID:
21048090
41.

Fluvoxamine improved cognitive impairments in a patient with schizophrenia.

Niitsu T, Shirayama Y, Fujisaki M, Hashimoto K, Iyo M.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1345-6. doi: 10.1016/j.pnpbp.2010.06.007. Epub 2010 Jun 19. No abstract available.

PMID:
20600473
42.

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia.

Shiina A, Shirayama Y, Niitsu T, Hashimoto T, Yoshida T, Hasegawa T, Haraguchi T, Kanahara N, Shiraishi T, Fujisaki M, Fukami G, Nakazato M, Iyo M, Hashimoto K.

Ann Gen Psychiatry. 2010 Jun 24;9:27. doi: 10.1186/1744-859X-9-27.

43.

Effects of the Ih blockers CsCl and ZD7288 on inherited epilepsy in Mongolian gerbils.

Matsuda Y, Saito N, Yamamoto K, Niitsu T, Kogure S.

Exp Anim. 2008 Jul;57(4):377-84.

44.

Holographic recording and retrieval of polarized light by use of polyester containing cyanoazobenzene units in the side chain.

Kawano K, Ishii T, Minabe J, Niitsu T, Nishikata Y, Baba K.

Opt Lett. 1999 Sep 15;24(18):1269-71.

PMID:
18079776
45.

Optical computing by a vector holographic memory system.

Kawano K, Minabe J, Niitsu T, Ishii T, Nishikata Y, Baba K.

Opt Lett. 2000 Aug 1;25(15):1077-9.

PMID:
18064276
46.

Imidazolidinium-based robust crypt with unique selectivity for fluoride anion.

Zhang BG, Cai P, Duan CY, Miao R, Zhu LG, Niitsu T, Inoue H.

Chem Commun (Camb). 2004 Oct 7;(19):2206-7. Epub 2004 Aug 19.

PMID:
15467874
47.

Intubating laryngeal mask for fibreoptic intubation--particularly useful during neck stabilization.

Asai T, Eguchi Y, Murao K, Niitsu T, Shingu K.

Can J Anaesth. 2000 Sep;47(9):843-8.

PMID:
10989852
48.

Changes in the cerebral arteriovenous oxygen content difference by surgical incision are similar during sevoflurane and isoflurane anaesthesia.

Inada T, Shingu K, Uchida M, Kawachi S, Tsushima K, Niitsu T.

Can J Anaesth. 1996 Oct;43(10):1019-24.

PMID:
8896853
49.

Point mutation of aldehyde dehydrogenase-2 gene in mutant strains of Long-Evans rats.

Nakajima M, Kato J, Kohgo Y, Takeichi N, Niitsu T.

Alcohol Alcohol Suppl. 1994;29(1):39-43.

PMID:
9063817
50.

[ECG changes associated with PGF2 alpha injection into the basal cistern of rabbits].

Fukuda M, Niitsu T, Yokoyama Y, Nakamura K, Uchida M.

Masui. 1991 Nov;40(11):1646-51. Japanese.

PMID:
1766116

Supplemental Content

Loading ...
Support Center